Corcept Therapeutics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Alaunos Therapeutics USD 1.09M 592K 2024-12
ANI Pharmaceuticals USD 144.86M 121K 2024-12
Ardelyx USD 48.65M 8.78M 2024-12
Aurora Cannabis CAD 108.71M 23.79M 2024-12
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Bristol-Myers Squibb USD 10.35B 2.46B 2024-12
Canopy Growth CAD 16.31M 69.8M 2024-12
Corcept Therapeutics USD 127.66M 9.62M 2024-12
Eli Lilly USD 3.27B 100.6M 2024-12
J&J USD 6.12B 1.28B 2024-12
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Merck USD 13.24B 1.35B 2024-12
Novartis USD 8.87B 4.74B 2024-12
Novartis USD 11.46B 2.15B 2024-12
Pacira USD 276.77M 30.81M 2024-12
Pfizer USD 1.04B 49M 2024-12
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
TG Therapeutics USD 179.89M 15.93M 2024-12



Corcept Therapeutics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.